Results 81 to 90 of about 9,470 (201)

The study of consistent properties of gelatinous shampoo with minoxidil

Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2016
The aim of the work is the study of consistent properties of gelatinous shampoo with minoxidil 1% for the complex therapy and prevention of alopecia. This shampoo with minoxidil was selected according to the complex physical-chemical, biopharmaceutical ...
I. V. Gnitko, V. V. Gladishev, A. P. Lisyanskaya, I. A. Biriuk   +3 more
doaj   +1 more source

Pustular dermatosis of the scalp due to topical minoxidil 5%

The Pan African Medical Journal, 2018
Topical minoxidil, the only approved treatment for female pattern hair loss (FPHL), has been associated with scalp allergic contact dermatitis (ACD). We report the case of a female patient who developed ACD from minoxidil solution.
Ouiam El Anzi, Badreddine Hassam
doaj   +1 more source

Evidence for α2-Adrenoceptor Agonist Activity of Minoxidil

, 1997
The present investigation was undertaken to study the mechanism of action of minoxidil using various smooth muscle preparations. Minoxidil (4.7 × 10−6 m to 4.7 × 10−4 m) produced a concentration-dependent inhibition of field stimulation ...
Nitin Sharma, Anita A Mehta, Ramesh K Goyal, Dev D Santani   +3 more
core   +1 more source

[Hypertrichosis during treatment with minoxidil]

, 1985
21 patients afflicted with severe arterial hypertension have been observed and followed for a period of five months to find the cause of hypertrichosis.
G. C. Ambroso, T. Povia, P. L. Bencini, F. Sala, C. Crosti   +4 more
core   +1 more source

Using a Natural Clay Mineral as an Active Drug Carrier to Promote Hair Growth

Pharmaceuticals
Background: Topical minoxidil remains the only FDA-approved treatment for hair loss, yet its clinical efficacy is compromised by organic-solvent-induced scalp irritation and poor patient adherence. This study aimed to evaluate natural illite as a carrier
Zhiqing Liu, Wenhua Huang, Shanhua Xu, Meilan Nan, Xian Cui, Yue Wang, Zhehu Jin, Wan Meng, Jingbi Meng, Longquan Pi   +9 more
doaj   +1 more source

Minoxidil induced hypertrichosis in children

The Pan African Medical Journal, 2014
Minoxidil is a strong arterial vasodilator used in the treatment of hypertension. In dermatology, topic minoxidil is widely used to treat hair fall. Hypertrichosis may occur if this form is misused.
Najwa Guerouaz, Ait Ourhroui Mohamed
doaj   +1 more source

Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients [PDF]

, 2018
Topical minoxidil is the only US FDA approved OTC drug for the treatment of androgenetic alopecia (AGA). Minoxidil is a pro-drug converted into its active form, minoxidil sulfate, by the sulfotransferase enzymes in the outer root sheath of hair follicles.
Sinclair, R, Kovacevic, M, McCoy, J, Situm, M, Sharma, A, Lotti, T, Goldust, M, Goren, A, Shapiro, J, Lukinovic Skudar, V, Dhurat, R   +10 more
core   +1 more source

Cardiac tamponade due to minoxidil use: a case report and review of the literature

European Journal of Case Reports in Internal Medicine
Minoxidil is a direct-acting vasodilator that reduces systemic vascular resistance by opening adenosine triphosphate (ATP)-sensitive potassium channels, leading to arteriolar smooth muscle vasodilation.
Prami Nakarmi, Joshua Hermiz, Roopeessh Vempati, Sanya Chandna, Umesh Bhagat, Stacy Loree, Christian Toquica Gahona   +6 more
doaj   +1 more source

From Hair Loss to Vision Loss: Minoxidil-Associated CRVO in a Young Female [PDF]

Introduction: Central retinal vein occlusion (CRVO) is a common retinal vascular disorder that is most often seen in older adults and individuals with vascular risk factors.
Abdelazim, Amr, Ji, Patrick Xiang, Sivachandran, Nirojini, Pickel, Lauren   +3 more
core   +1 more source

Clinical use of Minoxidil (Loniten)

, 1981
The powerful peripheral vasodilator minoxidil, in a dose of 5-40 mg daily, controlled the previously refractory blood pressure in 45 out of 47 patients for periods up to fifty-seven months.
P F B O'Regan, F D Thompson, A M Joekes
core   +1 more source